168 related articles for article (PubMed ID: 29051603)
1. Quantitative assessment of the blood-brain barrier opening caused by Streptococcus agalactiae hyaluronidase in a BALB/c mouse model.
Luo S; Cao Q; Ma K; Wang Z; Liu G; Lu C; Liu Y
Sci Rep; 2017 Oct; 7(1):13529. PubMed ID: 29051603
[TBL] [Abstract][Full Text] [Related]
2.
Ma K; Cao Q; Luo S; Wang Z; Liu G; Lu C; Liu Y
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29229728
[TBL] [Abstract][Full Text] [Related]
3. Two novel functions of hyaluronidase from Streptococcus agalactiae are enhanced intracellular survival and inhibition of proinflammatory cytokine expression.
Wang Z; Guo C; Xu Y; Liu G; Lu C; Liu Y
Infect Immun; 2014 Jun; 82(6):2615-25. PubMed ID: 24711564
[TBL] [Abstract][Full Text] [Related]
4. Group B
Vollmuth N; Bridgers BE; Armstrong ML; Wood JF; Gildea AR; Espinal ER; Hooven TA; Barbieri G; Westermann AJ; Sauerwein T; Foerstner KU; Schubert-Unkmeir A; Kim BJ
J Bacteriol; 2024 Jun; 206(6):e0008724. PubMed ID: 38771039
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronidase Impairs Neutrophil Function and Promotes Group B
Coleman M; Armistead B; Orvis A; Quach P; Brokaw A; Gendrin C; Sharma K; Ogle J; Merillat S; Dacanay M; Wu TY; Munson J; Baldessari A; Vornhagen J; Furuta A; Nguyen S; Adams Waldorf KM; Rajagopal L
mBio; 2021 Jan; 12(1):. PubMed ID: 33402537
[TBL] [Abstract][Full Text] [Related]
6. A Nonhemolytic Group B Streptococcus Strain Exhibits Hypervirulence.
Gendrin C; Vornhagen J; Armistead B; Singh P; Whidbey C; Merillat S; Knupp D; Parker R; Rogers LM; Quach P; Iyer LM; Aravind L; Manning SD; Aronoff DM; Rajagopal L
J Infect Dis; 2018 Mar; 217(6):983-987. PubMed ID: 29244079
[TBL] [Abstract][Full Text] [Related]
7. A new mass spectrometry based bioassay for the direct assessment of hyaluronidase activity and inhibition.
Britton ER; Ibberson CB; Horswill AR; Cech NB
J Microbiol Methods; 2015 Dec; 119():163-7. PubMed ID: 26519769
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtyping and characterization of bovine and human Streptococcus agalactiae isolates.
Sukhnanand S; Dogan B; Ayodele MO; Zadoks RN; Craver MP; Dumas NB; Schukken YH; Boor KJ; Wiedmann M
J Clin Microbiol; 2005 Mar; 43(3):1177-86. PubMed ID: 15750080
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial-Host Interactions Facilitate the Bacterial Pathogen Invading the Brain.
Al-Obaidi MMJ; Desa MNM
Cell Mol Neurobiol; 2018 Oct; 38(7):1349-1368. PubMed ID: 30117097
[TBL] [Abstract][Full Text] [Related]
10. Glutathione Synthesis Contributes to Virulence of
Walker EA; Port GC; Caparon MG; Janowiak BE
J Bacteriol; 2019 Oct; 201(20):. PubMed ID: 31331978
[No Abstract] [Full Text] [Related]
11. Adult zebrafish model of bacterial meningitis in Streptococcus agalactiae infection.
Patterson H; Saralahti A; Parikka M; Dramsi S; Trieu-Cuot P; Poyart C; Rounioja S; Rämet M
Dev Comp Immunol; 2012 Nov; 38(3):447-55. PubMed ID: 22867759
[TBL] [Abstract][Full Text] [Related]
12. SILAC and LC-MS/MS identification of Streptococcus equi ssp. zooepidemicus proteins that contribute to mouse brain microvascular endothelial cell infection.
Zhe M; Jie P; Hui Z; Bin X; Xiaomeng P; Huixing L; Chengping L; Hongjie F
Appl Microbiol Biotechnol; 2016 Aug; 100(16):7125-36. PubMed ID: 27178179
[TBL] [Abstract][Full Text] [Related]
13. Type 2 NADH Dehydrogenase Is the Only Point of Entry for Electrons into the Streptococcus agalactiae Respiratory Chain and Is a Potential Drug Target.
Lencina AM; Franza T; Sullivan MJ; Ulett GC; Ipe DS; Gaudu P; Gennis RB; Schurig-Briccio LA
mBio; 2018 Jul; 9(4):. PubMed ID: 29970468
[TBL] [Abstract][Full Text] [Related]
14. Current concepts on Escherichia coli K1 translocation of the blood-brain barrier.
Xie Y; Kim KJ; Kim KS
FEMS Immunol Med Microbiol; 2004 Nov; 42(3):271-9. PubMed ID: 15477040
[TBL] [Abstract][Full Text] [Related]
15. Natural Mutations in Streptococcus agalactiae Resulting in Abrogation of β Antigen Production.
Vasilyeva A; Santos Sanches I; Florindo C; Dmitriev A
PLoS One; 2015; 10(6):e0128426. PubMed ID: 26047354
[TBL] [Abstract][Full Text] [Related]
16. Streptococcus agalactiae GAPDH is a virulence-associated immunomodulatory protein.
Madureira P; Baptista M; Vieira M; Magalhães V; Camelo A; Oliveira L; Ribeiro A; Tavares D; Trieu-Cuot P; Vilanova M; Ferreira P
J Immunol; 2007 Feb; 178(3):1379-87. PubMed ID: 17237385
[TBL] [Abstract][Full Text] [Related]
17. Streptococcus agalactiae infection in zebrafish larvae.
Kim BJ; Hancock BM; Del Cid N; Bermudez A; Traver D; Doran KS
Microb Pathog; 2015 Feb; 79():57-60. PubMed ID: 25617657
[TBL] [Abstract][Full Text] [Related]
18. Identification of genes preferentially expressed by highly virulent piscine Streptococcus agalactiae upon interaction with macrophages.
Guo CM; Chen RR; Kalhoro DH; Wang ZF; Liu GJ; Lu CP; Liu YJ
PLoS One; 2014; 9(2):e87980. PubMed ID: 24498419
[TBL] [Abstract][Full Text] [Related]
19. Identification of CiaR Regulated Genes That Promote Group B Streptococcal Virulence and Interaction with Brain Endothelial Cells.
Mu R; Cutting AS; Del Rosario Y; Villarino N; Stewart L; Weston TA; Patras KA; Doran KS
PLoS One; 2016; 11(4):e0153891. PubMed ID: 27100296
[TBL] [Abstract][Full Text] [Related]
20. Strategy of Escherichia coli for crossing the blood-brain barrier.
Kim KS
J Infect Dis; 2002 Dec; 186 Suppl 2():S220-4. PubMed ID: 12424701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
